Internationally, psilocybin sits on a shared treaty baseline with wide national variation on top of it. Psilocybin and psilocin are listed under the 1971 United Nations Convention on Psychotropic Substances, [1] primary-legal Convention on Psychotropic Substances, 1971 Link → which sits alongside the 1961 Single Convention on Narcotic Drugs in the global drug-control framework. [2] primary-legal Single Convention on Narcotic Drugs, 1961 Link → These treaties commit signatory countries to control listed substances under their own law, which is why prohibition is the broad default and is reflected in the international control lists. [3] primary-legal List of Psychotropic Substances under International Control (Green List) Link → But countries differ in strictness, in how they treat possession, and in what research or medical pathways they allow. This article describes the structure — a treaty floor with national variation — and deliberately does not publish a country-by-country status list or identify places to obtain or use anything.
This is not legal advice; consult a qualified attorney licensed in the relevant jurisdiction. National laws vary and change; nothing here states the current law of any specific country.
Structure, not a destination guide. This article explains the international framework. It does not rank countries as places to obtain or use psychedelics, advise on travelling with substances, or interpret any country’s law for an individual.
A treaty baseline that binds states, not individuals
The international layer works through treaties that signatory countries agree to implement in their own legislation. Two are central. The 1961 Single Convention on Narcotic Drugs established the modern framework for narcotic control, [2] primary-legal Single Convention on Narcotic Drugs, 1961 Link → and the 1971 Convention on Psychotropic Substances extended international control to substances including psilocybin and psilocin. [1] primary-legal Convention on Psychotropic Substances, 1971 Link → The conventions generally commit signatories to limit use of the most strictly controlled substances to scientific and medical purposes. They do not regulate individuals directly; they bind countries to legislate, and it is each country’s domestic law that applies to people.
The substances under this framework are catalogued in international control lists, which is why psilocybin’s classification is broadly consistent at the treaty level across signatory states. [3] primary-legal List of Psychotropic Substances under International Control (Green List) Link →
Why the baseline produces a default of prohibition
Because most countries are signatories and have implemented the conventions, the global default is that psilocybin is a controlled substance, with use restricted by national law. This is the international counterpart to the United States federal floor: the same treaty obligations that the United States implements through the Controlled Substances Act also shape other countries’ laws. [4] primary-legal 21 U.S.C. § 812 — Schedules of controlled substances Link → It is also part of why reform tends to be gradual and carefully bounded — a country exploring medical or decriminalization models generally designs them to fit, rather than abandon, its treaty commitments.
Variation sits on top of the baseline
Within that shared floor, national approaches differ in ways that matter: how strictly a substance is scheduled, whether possession is treated as criminal or civil, whether research is facilitated or obstructed, and whether any medical or other pathway exists. The result is genuine variation between countries — but it is variation around prohibition, not a patchwork of open availability.
| Layer | What it is | What it does not do |
|---|---|---|
| UN conventions (1961, 1971) | International framework committing signatories to control | Do not regulate individuals directly |
| National implementation | Each country’s own controlled-substances law | Does not have to be identical between countries |
| National variation | Differences in scheduling, possession, research, medical access | Does not generally amount to open legality |
Why there is no country list here
This article does not give a country-by-country status table, for two deliberate reasons. First, such tables age quickly and are easily misread as travel or sourcing guidance, which this cluster does not provide. Second, ranking jurisdictions as places to obtain or use substances is outside its educational purpose. The point is to equip you to read a claim like “it’s legal in country X” critically — to ask which substance, which conduct, under what conditions, and as of what date — and then to verify it against that country’s official government sources. The general method for this is in how to read legal claims, and the same critical-reading discipline applied to health claims is in how to read microdosing claims.
- Treaties bind states
- The conventions commit signatory countries to legislate; they do not regulate individuals directly. [1] primary-legal Convention on Psychotropic Substances, 1971 Link →
- Prohibition is the default
- Wide treaty membership makes controlled status the global baseline for psilocybin. [3] primary-legal List of Psychotropic Substances under International Control (Green List) Link →
- Variation around a floor
- National differences are real but sit on top of a shared control framework.
- No destination ranking
- This article explains structure and declines to list or rank countries as places to obtain or use substances.
Frequently asked questions
Is psilocybin illegal everywhere?
There is a common international baseline but real national variation. Psilocybin and psilocin are listed under the 1971 United Nations Convention on Psychotropic Substances, [1] primary-legal Convention on Psychotropic Substances, 1971 Link → which most countries have signed and implemented in domestic law, so prohibition is the broad default. However, countries differ in how strictly they classify the substances, how they treat possession, and whether they allow research, medical, or other exceptions. There is no single global answer, and the picture changes; this article describes the structure, not the status of any one country today.
What do the UN drug-control treaties actually do?
The treaties create a framework that signatory countries agree to implement through their own national law. The 1961 Single Convention on Narcotic Drugs and the 1971 Convention on Psychotropic Substances classify substances into international schedules and commit signatories to control them, generally limiting use to scientific and medical purposes. [2] primary-legal Single Convention on Narcotic Drugs, 1961 Link → They do not directly regulate individuals; they bind states to legislate. Psilocybin sits under the 1971 convention, which is why national prohibition is widespread.
Why does the treaty backdrop make reform slow?
Because countries that have signed the conventions have treaty obligations to maintain certain controls, domestic reform has to be designed around those commitments. [3] primary-legal List of Psychotropic Substances under International Control (Green List) Link → This is part of why even jurisdictions exploring medical or decriminalization models tend to do so within carefully limited frameworks rather than by simply removing the substances from control. The treaty layer is context for understanding why change is gradual and constrained, not a separate rulebook that applies to a person directly.
Do some countries allow psilocybin?
Approaches vary, and some countries have narrower classifications, research or medical pathways, or different treatment of possession, while others enforce strict prohibition. Because this is exactly the kind of fast-changing, jurisdiction-specific detail that goes out of date, this article does not publish a country-by-country status list or identify places to obtain or use anything. The responsible approach is to verify the current law of a specific country against that country’s official government sources.
Why doesn't this page list which countries are most permissive?
Deliberately, for two reasons. First, such lists age quickly and are easily misread as travel or sourcing advice, which this cluster does not provide. Second, ranking jurisdictions as places to obtain or use substances is outside the educational purpose here. The aim is to explain the structure — a treaty baseline with national variation — so that any specific claim about a country can be read critically and checked against primary sources.